Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

362 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Innovations in research and clinical care using patient-generated health data.
Jim HSL, Hoogland AI, Brownstein NC, Barata A, Dicker AP, Knoop H, Gonzalez BD, Perkins R, Rollison D, Gilbert SM, Nanda R, Berglund A, Mitchell R, Johnstone PAS. Jim HSL, et al. Among authors: dicker ap. CA Cancer J Clin. 2020 May;70(3):182-199. doi: 10.3322/caac.21608. Epub 2020 Apr 20. CA Cancer J Clin. 2020. PMID: 32311776 Free PMC article. Review.
Intersection of Digital Health and Oncology.
Dicker AP, Jim HSL. Dicker AP, et al. JCO Clin Cancer Inform. 2018 Dec;2:1-4. doi: 10.1200/CCI.18.00070. JCO Clin Cancer Inform. 2018. PMID: 30652577 Free PMC article. Review. No abstract available.
Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group.
Narayan V, Harrison M, Cheng H, Kenfield S, Aggarwal R, Kwon D, McKay R, Hauger R, Hart N, Conzen S, Borno H, Jim H, Dicker A, Dorff T, Moslehi J, Mucci L, Parsons JK, Saad F, Soule H, Morgans A, Ryan CJ. Narayan V, et al. Urol Oncol. 2020 Mar;38(3):83-93. doi: 10.1016/j.urolonc.2019.10.006. Epub 2019 Nov 14. Urol Oncol. 2020. PMID: 31734020 Review.
Immune Checkpoint Inhibitor Therapy Toxicities.
Jim HSL, Knoop H, Dicker AP. Jim HSL, et al. Among authors: dicker ap. JAMA. 2021 Jul 6;326(1):87. doi: 10.1001/jama.2021.6030. JAMA. 2021. PMID: 34228072 No abstract available.
Meta-Analysis of Quality of Life in Cancer Patients Treated With Immune Checkpoint Inhibitors.
Gonzalez BD, Eisel SL, Bowles KE, Hoogland AI, James BW, Small BJ, Sharpe S, Hyland KA, Bulls HW, Christy SM, Mansfield J, Nelson AM, Alla R, Maharaj K, Kennedy B, Lafranchise E, Williams NL, Jennewein S, Oswald LB, Postow MA, Dicker AP, Jim HSL. Gonzalez BD, et al. Among authors: dicker ap. J Natl Cancer Inst. 2022 Jun 13;114(6):808-818. doi: 10.1093/jnci/djab171. J Natl Cancer Inst. 2022. PMID: 34508604 Free PMC article.
Development of a Functional Assessment of Chronic Illness Therapy item library and primary symptom list for the assessment of patient-reported adverse events associated with immune checkpoint modulators.
Webster KA, O'Connor ML, Hansen AR, Kircher S, Jim HSL, Dicker AP, Janda M, Ala-Leppilampi K, Bingham CO 3rd, Feliciano J, Lynn Henry N, Steffen McLouth LE, Cella D. Webster KA, et al. Among authors: dicker ap. J Cancer Metastasis Treat. 2020;6:8. doi: 10.20517/2394-4722.2019.38. Epub 2020 Mar 13. J Cancer Metastasis Treat. 2020. PMID: 34790879 Free PMC article.
Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive Disease.
Awasthi S, Grass GD, Torres-Roca J, Johnstone PAS, Pow-Sang J, Dhillon J, Park J, Rounbehler RJ, Davicioni E, Hakansson A, Liu Y, Fink AK, DeRenzis A, Creed JH, Poch M, Li R, Manley B, Fernandez D, Naghavi A, Gage K, Lu-Yao G, Katsoulakis E, Burri RJ, Leone A, Ercole CE, Palmer JD, Vapiwala N, Deville C, Rebbeck TR, Dicker AP, Kelly W, Yamoah K. Awasthi S, et al. Among authors: dicker ap. J Natl Cancer Inst. 2022 Dec 8;114(12):1656-1664. doi: 10.1093/jnci/djac162. J Natl Cancer Inst. 2022. PMID: 36053178 Free PMC article.
362 results